KMDA
KamadaCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Primary-source evidence improved after earnings: Q1 revenue grew 3% to $45.2M, net income rose 4% to $4.1M, the delayed order was delivered in April, and management reaffirmed 2026 guidance while pointing to rising demand for KEDRAB, KAMRAB and VARIZIG, plasma-center ramp potential, biosimilar launches and possible business-development activity [#PR-2026-05-13].
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Analyst coverage appears thin, and post-earnings revision data is not available in the packet, lowering confidence in any target-based upside signal.
Momentum
28
Value
66
Sentiment
67
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $8.80 · Bull $11.50 · Bear $6.40
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-16 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $13.00
Why
Momentum28 · Δ7d -
Value66 · Δ7d +0.6
Sentiment67 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Sentiment · See AI snapshot
Momentum
28
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
66
32% active weight
Current posture
7d trendFlat
Δ7d
+0.6
Δ21d
+1.3
Sentiment
67
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 28.1 / Value 66.4 / Sentiment 67.3
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$446.84M
Beta
0.94
Shares Out
57.68M
P/E (TTM)
20.6
P/S (TTM)
2.39
P/FCF (TTM)
22.79
Rev YoY
+12.6%
EPS YoY
+28.6%
Gross Margin
+43.8%
Op Margin
+15.9%
Net Debt
-$67.37M
Current Ratio
4.03
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology